ArticleMethods in molecular biology (Clifton, N.J.)2026
NanoPlex: A Universal Strategy to Multiplex Immunostainings for Fluorescence Microscopy Using Secondary Nanobodies.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluorescence microscopy techniques rely strongly on revealing targets of interest using affinity binders, such as antibodies, through a process known as immunostaining or immunofluorescence. Immunostaining is typically achieved using a primary antibody against a specific target of interest, which is then detected by a fluorescently labeled secondary antibody that recognizes the primary antibody's species. This procedure, known as indirect immunofluorescence, constrains the detection of multiple targets by requiring primary antibodies from different species. Here, we describe NanoPlex, a methodology that allows multitarget detection in a species-independent fashion. NanoPlex employs secondary single-domain antibodies (sdAbs, or nanobodies) that enable the simultaneous use of multiple primary antibodies originating from the same species. In addition, these secondary sdAbs are engineered to allow for a mild and specific removal of the fluorescence signal after imaging, enabling a new round of immunostaining and imaging. NanoPlex includes secondary sdAbs with different functional groups, which support directed signal erasing upon application of either UV light (OptoPlex), proteolytic enzyme (EnzyPlex), or a reducing agent (ChemiPlex), fulfilling the demands of various experimental setups. This approach, which involves directed signal removal and re-staining of new targets on the same sample, permits the visualization of multiple targets under the same context in virtually any antibody-based application. Here, we present a detailed protocol for performing NanoPlex on cell cultures, including a practical example for 6-plex in ChemiPlex mode. In this practical example, three iterations are performed while employing dual-color confocal microscopy on each cycle. Notes have been included for step modifications required for EnzyPlex and OptoPlex.
Indexed as
Identifiers
42091818What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.